Trabectedin as a chemotherapy option for patients with BRCA deficiency

Title
Trabectedin as a chemotherapy option for patients with BRCA deficiency
Authors
Keywords
Trabectedin, Yondelis®, BRCA, Mutations, Sarcoma, Breast, Ovarian cancer
Journal
CANCER TREATMENT REVIEWS
Volume 50, Issue -, Pages 175-182
Publisher
Elsevier BV
Online
2016-09-17
DOI
10.1016/j.ctrv.2016.09.009

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now